Long Term Post Marketing Drug Use Result Survey for Blinatumomab in Japan (20180238) (Blinatumomab Long Term PMS Japan)

09/05/2019
30/10/2025
EU PAS number:
EUPAS29685
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Protocol-Published Original blinatumomab 20180238 .pdf

English (1.03 MB - PDF) View document
Updated protocol

blinatumomab_20180238_abstract ORSR_Redacted.pdf

First published: 24/10/2025
English (51.52 KB - PDF) View document
Study results
Study report
Other information